Henry Schein Stock Price, News & Analysis

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.

Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.

Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.

Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.

In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.

For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.